We include several reports from this recent European conference, held this year in Madrid.

These include:

• New European guidelines launched

• Saquinavir/r non-inferior to Kaletra at week 48 (Gemini study)

• Darunavir once-daily is non-inferior to lopinavir/r in treatment-naive patients at 48 weeks (Artemis study)

• Tesamorelin (TH9507) reduces abdominal fat in patients with HIV-related lipodystrophy: 52 week results

• Drug interaction studies presented at EACS

Abstracts are posted online to the conference website and it is very encouraging to see that web casts of the oral presentations, including late-breakers, are also online for the first time:

http://www.multiwebcast.com/eacs/2007/11th

Presentations from the excellent pre-conference educational course, together with some of the pharmaceutical satellite sessions, are also posted from links to the conference home page:

http://www.eacs-conference2007.com/